| Literature DB >> 35584711 |
Stylianos Dragasis1, Konstantinos Vlachos2, Ourania Kariki2, Stavroula Koskina2, Andromahi Zygouri2, Ilias G Patsiotis3, Aris Anastasakis2, George Athanasopoulos2, Konstantinos Ritsatos2, Konstantinos Letsas2, Michael Efremidis2.
Abstract
Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.Entities:
Keywords: Arterial thromboembolism; Atrial fibrillation; Hypertrophic cardiomyopathy
Mesh:
Year: 2022 PMID: 35584711 DOI: 10.1016/j.hjc.2022.05.002
Source DB: PubMed Journal: Hellenic J Cardiol ISSN: 1109-9666 Impact factor: 5.795